Targeting MRP2 in HepG2 Cells Using the CRISPR-Cas9 System to Reverse Oxaliplatin Resistance
As a third-generation platinum-based anticancer drug, oxaliplatin is critically important in the treatment of hepatocellular carcinoma (HCC), colorectal (CRC) and other GI cancers, improving disease- and progression-free survival when added to combination chemotherapy regimens. However, due to the i...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Published: |
Auckland University of Technology,
2019-09-25T23:45:49Z.
|
| Subjects: | |
| Online Access: | Get fulltext |